Skip to main content
. Author manuscript; available in PMC: 2022 Apr 5.
Published in final edited form as: Oral Oncol. 2020 May 30;108:104819. doi: 10.1016/j.oraloncology.2020.104819

Table 3.

Mutually-adjusted hazard ratios of all cases in the primary radiation cohort and surgical cohort.

Primary Radiation Surgical Cohort
HR(95% CI) p-value HR*(95 % CI) p-value
Duration of Radiation Therapy (Days) Duration of Radiation Therapy (Days)
47–53 1 40–46 1
54–60 1.23 (1.19, 1.27) <0.001 47–53 1.11 (1.04, 1.18) 0.001
61–67 1.33 (1.28, 1.39) <0.001 54–60 1.34 (1.24, 1.46) <0.001
68–73 1.5 (1.41, 1.6) <0.001 61–67 1.47 (1.31, 1.63) <0.001
74–80 1.65 (1.53, 1.78) <0.001 68–74 1.34 (1.13, 1.59) 0.001
81 + 1.69 (1.58, 1.81) <0.001 75+ 1.61 (1.37, 1.88) <0.001
Time to Treatment Initiation (Days) Time to Treatment Initiation (Days)
<28 1 <28 1
28 to 56 0.98 (0.94, 1.01) 0.231 28 to 56 1.04 (0.98, 1.1) 0.199
56+ 1.05 (1.01, 1.09) 0.017 56+ 1.01 (0.93, 1.1) 0.78
Radiation Dose Radiation Dose
<66 gy 1 <60 gy 1
≥66 gy 0.91 (0.88, 0.93) <0.001 ≥60 gy 0.96 (0.91, 1.02) 0.162
Post-Operative Adjuvant Radiation Time (Days)
-- -- -- <42 1
-- -- -- 42 to 48 1.08 (1.00, 1.17) 0.044
-- -- -- 49+ 1.19 (1.12, 1.27) <0.001
-- -- -- Margin Status
-- -- -- Negative 1
-- -- -- Positive 1.21 (1.14, 1.3) <0.001
*

Adjusted for insurance, median income quartile, site, race, T stage, N stage, charlson comorbidity, treatment, age

HR: Hazard Ratio; CI: Confidence Interval